Tag Archives: TSLF

Top 10 Medical Stocks To Own Right Now

Primo Water (NASDAQ:PRMW) had its price objective hoisted by analysts at BMO Capital Markets from $15.00 to $16.00 in a research note issued on Thursday. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price target points to a potential upside of 0.88% from the company’s current price.

PRMW has been the subject of a number of other research reports. ValuEngine upgraded shares of Primo Water from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. BidaskClub lowered shares of Primo Water from a “hold” rating to a “sell” rating in a research note on Tuesday, March 13th. Barrington Research restated a “buy” rating and set a $20.00 price target on shares of Primo Water in a research note on Friday, April 6th. B. Riley set a $18.00 price target on shares of Primo Water and gave the company a “buy” rating in a research note on Monday, March 5th. Finally, William Blair began coverage on shares of Primo Water in a research note on Thursday. They set an “outperform” rating for the company. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $17.50.

Top 10 Medical Stocks To Own Right Now: THL Credit Senior Loan Fund(TSLF)

THL Credit Senior Loan Fund is a non-diversified, closed-end management investment company (Fund). The Fund’s investment objective is to provide current income and preservation of capital primarily through investments in United States dollar-denominated senior secured corporate loans and notes. Under normal market conditions, the Fund will invest 100% of its Managed Assets in the securities of issuers located in North America and does not currently intend to invest a material amount of its Managed Assets outside the United States. It invests in sectors, such as Business, Services, Healthcare and Pharmaceuticals, Retail, Software, Advertising, Printing and Publishing, and Diversified and Services, among others. Four Wood Capital Advisors LLC serves as the Fund’s investment adviser. Advisors’ Opinion:

Top 10 Medical Stocks To Own Right Now: Catalyst Biosciences, Inc. (CBIO)

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. Its product pipeline includes CB 813d, a Factor VIIa drug candidate that completed a Phase I clinical trials evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity in severe hemophilia A and B patients with and without inhibitors. The company’s preclinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of patients with hemophilia B; and a Factor Xa variant. It is also developing CB 2782, an anti-C3 inflammation development candidate for the treatment of delayed graft function in kidney transplants; and an ophthalmic anti-C3 candidate for treatment of dry age-related macular degeneration. The company has collaboration agreement with Pfizer, Inc. for the development of human Factor VIIa products; and ISU Abxis for development and manufacturing of the Factor IX products through Phase I/II clinical trials. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Catalyst Biosciences (CBIO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Catalyst Biosciences Inc. (NASDAQ: CBIO) is scheduled to present interim data from its Phase 2 study of Marzeptacog alfa (MarzAA) on July 18. This data will be pertaining to the subcutaneous efficacy trial in individuals with hemophilia A or B with inhibitors to evaluate the ability of MarzAA to minimize spontaneous bleeding episodes.

  • [By Joseph Griffin]

    B. Riley lowered shares of Catalyst Biosciences (NASDAQ:CBIO) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat reports. They currently have $12.50 price objective on the biopharmaceutical company’s stock, down from their prior price objective of $44.00.

  • [By Cory Renauer]

    If you’re looking for biotech stock bargains, the scrap heap isn’t a bad place to start. Hardly a day goes by without a biotech meltdown somewhere, and clinical trial mishaps led to market clubbings for Anika Therapeutics (NASDAQ:ANIK) and Catalyst Biosciences (NASDAQ:CBIO) earlier this week.

Top 10 Medical Stocks To Own Right Now: RELX PLC(RELX)

RELX Group is a global provider of information and analytics for professional and business customers across industries.
Our goal is to help customers make better decisions, get better results and be more productive. We do this by leveraging a deep understanding of our customers to create innovative solutions which combine content and data with analytics and technology in global platforms.
The Group has customers in more than 180 countries and has offices in about 40 countries. The Group employs approximately 30,000 staff.
We operate in four major market segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions.

? Scientific, Technical & Medical helps customers advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity, and improve outcomes.   Advisors’ Opinion:

  • [By Joseph Griffin]

    First Republic Investment Management Inc. acquired a new position in shares of Relx PLC (NYSE:RELX) in the 2nd quarter, Holdings Channel reports. The fund acquired 13,205 shares of the technology company’s stock, valued at approximately $287,000.

  • [By Joseph Griffin]

    Relx PLC (NYSE:RELX)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $20.27 and last traded at $20.29, with a volume of 6975 shares traded. The stock had previously closed at $20.35.

  • [By Joseph Griffin]

    Relx (NYSE: RELX) and Cambium Learning Group (NASDAQ:ABCD) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Top 10 Medical Stocks To Own Right Now: Cherry Hill Mortgage Investment Corporation(CHMI)

Cherry Hill Mortgage Investment Corporation, incorporated on October 31, 2012, is a residential real estate finance company. The Company is focused on acquiring, investing in and managing residential mortgage assets in the United States. Its principal objective is to generate attractive current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The Company focuses on attaining this objective, subject to market conditions and availability and terms of financing, by selectively constructing and managing a targeted portfolio of Servicing Related Assets, residential mortgage-backed securities (RMBS), prime mortgage loans and other cashflowing residential mortgage assets. The Company operates its business through segments, including investments in RMBS; investments in Servicing Related Assets, and All Other. The Company’s targeted asset classes include servicing related assets consisting of mortgage servicing rights (MSRs) and Excess MSRs; RMBS, including Agency RMBS, residential mortgage pass-through certificates, collateralized mortgage obligations (CMOs) (interest-only security (IO) and inverse IOs) and to-be-announced (TBA), and prime mortgage loans. The Company is externally managed by Cherry Hill Mortgage Management, LLC.

The Company also may generate MSRs through the purchase of prime mortgage loans. Its RMBS strategy focuses primarily on the acquisition and ownership of Agency RMBS that are whole-pool, residential mortgage pass-through certificates. However, from time to time, the Company invests in CMOs, including IOs and inverse IOs. Its RMBS strategy includes selective investments in non-Agency RMBS, including government-sponsored enterprise (GSE) risk-sharing securities.

Advisors’ Opinion:

  • [By Max Byerly]

    Cherry Hill Mortgage Investment (NYSE:CHMI) and Great Portland Estates (OTCMKTS:GPEAF) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

  • [By Ethan Ryder]

    Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Cherry Hill Mortgage Investment Corp (NYSE:CHMI) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 152,335 shares of the real estate investment trust’s stock, valued at approximately $2,721,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.98% of Cherry Hill Mortgage Investment as of its most recent filing with the SEC.

Top 10 Medical Stocks To Own Right Now: Briggs & Stratton Corporation(BGG)

Briggs & Stratton Corporation designs, manufactures, markets, sells, and services air cooled gasoline engines for outdoor power equipment. It operates in two segments, Engines and Products. The Engines segment offers four-cycle aluminum alloy gasoline engines that are used primarily by the lawn and garden equipment industry. Its products are used in various lawn and garden equipment applications, including walk-behind lawn mowers, riding lawn mowers, garden tillers, and snow throwers, as well as products for industrial, construction, agricultural, and other consumer applications that include portable and standby generators, pumps, and pressure washers. This segment also manufactures and sells replacement engines and service parts to sales and service distributors. The Products segment offers portable and standby generators, pressure washers, snow throwers, lawn and garden powered equipment, turf care, and job site products. This segment sells its products through various channels of retail distribution, including consumer home centers, warehouse clubs, mass merchants, and independent dealers under its brands, including Briggs & Stratton, Simplicity, Snapper, Snapper Pro, Ferris, PowerBoss, Allmand, Billy Goat, Murray, Branco, and Victa, as well as other brands, such as Craftsman, GE, and Troy-Bilt. The company serves original equipment manufacturers worldwide. Briggs & Stratton Corporation was founded in 1908 and is headquartered in Wauwatosa, Wisconsin.

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Briggs & Stratton (BGG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Generac Holdings Inc. (NYSE: GNRC) was up less than 1% at $59.20 late on Tuesday, but that is actually up by over 6% from last Friday’s close for the generator maker before the storm threat was so imminent. Briggs & Stratton Corp. (NYSE: BGG) is also in that field and its gain of just 0.3% to $20.45 late on Tuesday was actually up only about 1% from last Friday as the company is more diversified

  • [By Motley Fool Transcriber]

    Briggs & Stratton Corporation (NYSE: BGG)Q4 2018 Briggs & Stratton Corp Earnings CallAug. 16, 2018, 2 p.m. EDT

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Own Right Now: EP Energy Corporation(EPE)

EP Energy Corporation (EP Energy), incorporated on August 8, 2013, is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States. The Company operates through a diverse base of producing assets and are focused on creating value through the development of its drilling inventory located in four areas: the Eagle Ford Shale (South Texas), the Wolfcamp Shale (Permian Basin in West Texas), the Altamont Field in the Uinta Basin (Northeastern Utah) and the Haynesville Shale (North Louisiana). In its operating areas, it has identified approximately 5,710 drilling locations (including over 860 drilling locations to which it has attributed proved undeveloped reserves).

The Company has proved reserves of approximately 546.0 million barrels of oil equivalent (MMBoe) and it has an average net daily production of over 109,680 barrel of oil equivalent per day (Boe/d). Approximately 240 MMBoe of its total proved reserves are proved developed producing assets, which generates an average production of over 109.7 million barrels of oil equivalent per day (MBoe/d) from approximately 1,600 wells. The Company has approximately 300 MMBbls of proved oil reserves, over 90 MMBbls of proved natural gas liquids (NGLs) reserves and approximately 940 billion cubic feet (Bcf) of proved natural gas reserves.

Eagle Ford Shale

The Eagle Ford Shale, located in South Texas, is an unconventional oil plays in the United States. The Eagle Ford formation in La Salle county has approximately 120 feet of net thickness (over 160 feet gross). The Company has approximately 94,150 net (over 88,890 gross) acres in the Eagle Ford, in which it has identified over 970 drilling locations. The Company has approximately 570 net producing wells (over 560 net operated wells) and running one rig in this program. EP Energy’s average net daily production is approximately 58,190 Boe/d.

!

Wolfcamp Shale

The Wolfcamp Shale is located in the Permian Basin. The Wolfcamp A, B and C zones combine for over 750 feet of net (approximately 1,000 feet of gross) thickness. The Company has approximately 178,110 net (over 178,280 gross) acres in the Wolfcamp, in which it has identified approximately 3,260 drilling locations in the Wolfcamp A, B and C zones. EP Energy has approximately 240 net operated producing wells. Its average net daily production is over 19,850 Boe/d.

Altamont

The Altamont field is located in the Uinta Basin in northeastern Utah. The Company’s operations are focused on developing the Altamont Field Complex (consisting of the Altamont, Bluebell and Cedar Rim fields). It owns approximately 180,940 net (over 323,210 gross) acres in Duchesne and Uinta Counties. The Altamont Field Complex has a gross pay interval thickness of over 4,300 feet. Its commingled production is from over 1,500 feet of net stimulated rock. The Company’s activity is focused on the development of its vertical inventory on approximately 80-acre and 160-acre spacing. The Company has identified approximately 1,280 drilling locations. EP Energy has approximately 390 net producing wells (over 380 net operated wells). The Company’s average net daily production is approximately 17,140 Boe/d.

Haynesville Shale

The Company holds natural gas assets in the Haynesville Shale, located in East Texas and Northern Louisiana. The Company’s operations are concentrated primarily in Desoto Parish, Louisiana in the Holly Field. It has approximately 34,170 net (over 52,930 gross) acres in this area. EP Energy has identified over 190 drilling locations. The Company’s average net daily production is approximately 90 million cubic feet per day (MMcf/d).

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    EP Energy Corp  (NYSE:EPE)Q4 2018 Earnings Conference CallMarch 15, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enterprise GP (EPE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enterprise GP Holdings L.P. (NYSE:EPE) shares were up 5.5% during trading on Wednesday . The stock traded as high as $2.55 and last traded at $2.51. Approximately 939,243 shares traded hands during mid-day trading, a decline of 13% from the average daily volume of 1,077,065 shares. The stock had previously closed at $2.38.

Top 10 Medical Stocks To Own Right Now: MuniVest Fund, Inc.(MVF)

BlackRock MuniVest Fund, Inc. (the Fund), formerly known as MuniVest Fund, Inc., is a non-diversified, closed-end management investment company. The Fund seeks to provide a high a level of current income exempt from federal income taxes by investing primarily in a portfolio of long-term, investment-grade municipal obligations, the interest on which is exempt from federal income taxes.

BlackRock MuniVest Fund, Inc. may invest in certain securities, whose income return is inversely related to changes in a floating interest rate (inverse floaters). The Fund may invest in swap agreements. The Fund may also purchase and write call and put options. BlackRock MuniVest Fund, Inc.’s investment advisor is BlackRock Advisors, LLC, a wholly owned subsidiary of BlackRock, Inc. The Fund’s sub-advisor is BlackRock Investment Management, LLC.

Advisors’ Opinion:

  • [By Max Byerly]

    BlackRock MuniVest Fund Inc. (NYSEAMERICAN:MVF) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Stockholders of record on Friday, September 14th will be paid a dividend of 0.041 per share by the investment management company on Monday, October 1st. This represents a $0.49 annualized dividend and a dividend yield of 5.57%. The ex-dividend date of this dividend is Thursday, September 13th.

Top 10 Medical Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses on pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology. The Company has a range of drugs to treat drug-resistant bacterial infections, systemic fungal infections and drug-resistant tumors. The Company’s anti-infectives, including isavuconazole and ceftobiprole are in late-stage clinical development, while the novel antibiotic, BAL30072 and the oncology compound, BAL101553 are in clinical phase I. The Company’s subsidiaries include Basilea Pharmaceutica China Ltd., Basilea Pharmaceuticals A/S, Basilea Pharma SAS, Basilea Pharmaceutica Deutschland GmbH, Basilea Pharmaceutica International Ltd., BPh Investitionen Ltd., Basilea Medical Ltd. and Basilea Pharmaceuticals Ltd. Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Medical Stocks To Own Right Now: SunCoke Energy Partners, L.P.(SXCP)

SunCoke Energy Partners, L.P., (the “Partnership,” “we,” “our” and “us”), is a Delaware limited partnership formed in July 2012, which primarily produces coke used in the blast furnace production of steel. We also provide coal handling and/or mixing services at our Coal Logistics terminals. At December 31, 2015, we owned a 98.0 percent interest in Haverhill Coke Company LLC (“Haverhill”), Middletown Coke Company, LLC (“Middletown”) and Gateway Energy and Coke Company, LLC (“Granite City”). At December 31, 2015, SunCoke Energy, Inc. (“SunCoke”) owned the remaining 2.0 percent interest in each of Haverhill, Middletown, and Granite City, and, through its subsidiary, owned a 53.9 percent partnership interest in us and all of our incentive distribution rights and indirectly owns and controls our general partner, which holds a 2.0 percent general partner interest in us. Coke is a principal raw material in the blast furnace steelmaking process.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Bramshill Investments LLC cut its stake in SunCoke Energy Partners LP (NYSE:SXCP) by 4.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 113,454 shares of the energy company’s stock after selling 4,786 shares during the period. Bramshill Investments LLC’s holdings in SunCoke Energy Partners were worth $1,702,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE:SXCP) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Teligent (NASDAQ:TLGT) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Stephan Byrd]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get SunCoke Energy Partners alerts:

    SunCoke Energy Partners LP Declares Quarterly Dividend of $0.40 (SXCP) (americanbankingnews.com) SunCoke Energy Partners (SXCP) Scheduled to Post Earnings on Wednesday (americanbankingnews.com) SunCoke Energy Partners LP (SXCP) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Head to Head Survey: SunCoke Energy Partners (SXCP) vs. APERAM/SH N Y REGISTRY SH (APEMY) (americanbankingnews.com)

    Shares of SunCoke Energy Partners traded down $0.05, hitting $15.85, during trading on Friday, MarketBeat reports. 105,181 shares of the company were exchanged, compared to its average volume of 66,406. The firm has a market capitalization of $735.01 million, a price-to-earnings ratio of 9.61 and a beta of 1.44. SunCoke Energy Partners has a fifty-two week low of $14.70 and a fifty-two week high of $21.95. The company has a quick ratio of 0.83, a current ratio of 1.54 and a debt-to-equity ratio of 1.34.

  • [By Shane Hupp]

    SunCoke Energy Partners (NYSE: SXCP) and AK Steel (NYSE:AKS) are both small-cap oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Top 10 Medical Stocks To Own Right Now: TG Therapeutics, Inc.(TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4); and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101; Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; and Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology. It also has a collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Todd Campbell]

    Fueled by trial data, TG Therapeutics (NASDAQ:TGTX) shares skyrocketed 69.5% in February, according to S&P Global Market Intelligence.

    So what

    On Jan. 30, data from phase 1 trials evaluating TG Therapeutics’ ublituximab and umbralisib alongside J&J and AbbVie’s Imbruvica was published in Lancet, a respected industry journal. 

  • [By Logan Wallace]

    Shares of TG Therapeutics Inc (NASDAQ:TGTX) have received a consensus rating of “Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $12.30.

  • [By George Budwell]

    Shares of the B-cell malignancy and autoimmune disease specialist TG Therapeutics (NASDAQ:TGTX) fell by an eye-popping 55.9% last month, according to data from S&P Global Market Intelligence. What triggered this dramatic sell-off?

Top 5 Performing Stocks To Watch For 2019

Wall Street had a down day on Thursday, with the trade-sensitive industrial side of the market seeing the largest declines on news that the U.S. and Canada had imposed a set of matching tariffs on each other. The Dow lost more than 200 points, but declines were somewhat less extensive on a percentage basis for other parts of the market. Crude oil prices also moved lower, and the general sense among investors was one of uncertainty about how these initial disputes would evolve over time. Moreover, some bad news from key sectors of the economy weighed on individual stocks. Dollar Tree (NASDAQ:DLTR), Guess? (NYSE:GES), and Micron Technology (NASDAQ:MU) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Dollar Tree cuts its 2018 guidance

Shares of Dollar Tree plunged 14% after the dollar-store retailer announced its fiscal first-quarter results. The company said that revenue rose 5%, with Dollar Tree stores reporting a 4% rise in same-store sales. Yet the company’s Family Dollar stores underperformed, posting a same-store sales decline of 1.1% compared to the year-ago quarter. Executives blamed the subpar results on a cold spring, an early Easter holiday, and higher freight costs for moving goods to its store locations. Yet although the company said warmer weather has helped the business recover, Dollar Tree still cut its earnings projections for the full year, and investors seemed to ignore the potential long-term positives of strategic moves like refinancing its debt. The news came as a surprise to those who’ve seen dollar stores as outperforming their upscale rivals.

Top 5 Performing Stocks To Watch For 2019: GAMCO Natural Resources, Gold & Income Tust (GNT)

Advisors’ Opinion:

  • [By Max Byerly]

    Golem (CURRENCY:GNT) traded 0.3% lower against the US dollar during the twenty-four hour period ending at 21:00 PM Eastern on May 19th. One Golem token can now be bought for approximately $0.51 or 0.00006248 BTC on popular cryptocurrency exchanges including Mercatox, Zebpay, Liqui and Cryptopia. Over the last week, Golem has traded 9.1% lower against the US dollar. Golem has a market cap of $428.99 million and approximately $7.17 million worth of Golem was traded on exchanges in the last 24 hours.

  • [By Joseph Griffin]

    Golem (CURRENCY:GNT) traded 15.7% higher against the dollar during the 24 hour period ending at 0:00 AM Eastern on August 17th. One Golem token can currently be purchased for approximately $0.17 or 0.00002636 BTC on exchanges including Zebpay, Poloniex, OKEx and Bittrex. In the last week, Golem has traded up 1.7% against the dollar. Golem has a total market capitalization of $165.19 million and $7.99 million worth of Golem was traded on exchanges in the last 24 hours.

  • [By Shane Hupp]

    Golem (CURRENCY:GNT) traded 0.3% higher against the U.S. dollar during the 1-day period ending at 13:00 PM Eastern on September 30th. Golem has a market capitalization of $147.49 million and approximately $1.20 million worth of Golem was traded on exchanges in the last day. During the last seven days, Golem has traded up 4.8% against the U.S. dollar. One Golem token can currently be purchased for approximately $0.15 or 0.00002326 BTC on major exchanges including HitBTC, OOOBTC, Iquant and Zebpay.

  • [By Max Byerly]

    TRADEMARK VIOLATION NOTICE: “Gamco Natural Resources Gold & Incm Trst (GNT) Shares Sold by Oppenheimer & Co. Inc.” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/4140836/gamco-natural-resources-gold-incm-trst-gnt-shares-sold-by-oppenheimer-co-inc.html.

Top 5 Performing Stocks To Watch For 2019: Citizens Financial Group, Inc.(CFG)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Citizens Financial Group Inc (NYSE: CFG) shares were down Tuesday, dragged by macro concerns following the rise in Italian sovereign debt yields and a 14-basis point decline in the 10-year U.S. treasury yield.

  • [By Ethan Ryder]

    Citizens Financial Group Inc (NYSE:CFG) insider Randall J. Black sold 792 shares of Citizens Financial Group stock in a transaction on Tuesday, June 5th. The shares were sold at an average price of $41.49, for a total value of $32,860.08. Following the completion of the transaction, the insider now owns 34,258 shares in the company, valued at $1,421,364.42. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

  • [By Max Byerly]

    Citizens Financial Group (NYSE:CFG) and State Bank Financial (NASDAQ:STBZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Logan Wallace]

    Shares of Citizens Financial Group Inc (NYSE:CFG) have been given a consensus recommendation of “Hold” by the fourteen analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $46.38.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Citizens Financial Group (CFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Mackay Shields LLC decreased its stake in shares of Citizens Financial Group Inc (NYSE:CFG) by 52.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 92,270 shares of the bank’s stock after selling 102,210 shares during the period. Mackay Shields LLC’s holdings in Citizens Financial Group were worth $3,589,000 as of its most recent SEC filing.

Top 5 Performing Stocks To Watch For 2019: THL Credit Senior Loan Fund(TSLF)

Advisors’ Opinion:

Top 5 Performing Stocks To Watch For 2019: Optical Cable Corporation(OCC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Optical Cable Co. (NASDAQ:OCC) Chairman Neil D. Wilkin, Jr. sold 10,000 shares of Optical Cable stock in a transaction on Tuesday, June 19th. The stock was sold at an average price of $3.50, for a total transaction of $35,000.00. Following the transaction, the chairman now directly owns 1,074,405 shares in the company, valued at $3,760,417.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

  • [By Logan Wallace]

    Octoin Coin (CURRENCY:OCC) traded 7% higher against the US dollar during the 24 hour period ending at 19:00 PM Eastern on May 12th. One Octoin Coin coin can now be bought for approximately $2.51 or 0.00029499 BTC on popular exchanges including Exrates and YoBit. Octoin Coin has a market cap of $926,548.00 and approximately $1.02 million worth of Octoin Coin was traded on exchanges in the last day. In the last week, Octoin Coin has traded 23.4% lower against the US dollar.

  • [By Shane Hupp]

    Media coverage about Optical Cable (NASDAQ:OCC) has trended positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Optical Cable earned a coverage optimism score of 0.31 on Accern’s scale. Accern also gave news stories about the communications equipment provider an impact score of 46.3231627277527 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 5 Performing Stocks To Watch For 2019: HP Inc.(HPQ)

Advisors’ Opinion:

  • [By Max Byerly]

    DNB Asset Management AS grew its holdings in HP Inc. (NYSE:HPQ) by 251.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,944,443 shares of the computer maker’s stock after purchasing an additional 3,537,963 shares during the quarter. HP accounts for about 1.4% of DNB Asset Management AS’s holdings, making the stock its 13th biggest holding. DNB Asset Management AS’s holdings in HP were worth $127,418,000 as of its most recent SEC filing.

  • [By Chris Lange]

    When HP Inc. (NYSE: HPQ) released its fiscal second-quarter financial results after the markets closed on Tuesday, the company said that it had $0.48 in earnings per share (EPS) on $14.0 billion in revenue. That compared with consensus estimates of $0.48 in EPS on revenue of $13.57 billion, as well as the $0.40 per share and $12.38 billion posted in the same period of last year.

  • [By Leo Sun]

    HP (NYSE:HPQ) is the biggest PC maker in the world. Its printing business, which recently acquired Samsung’s printing unit, is also one of the world’s top manufacturers of consumer, commercial, and 3D printers.